114-49-8 Usage
Chemical Properties
Off-White Solid
Uses
An acetylcholine antagonist. Used in treatment of motion sickness; antiemetic; antispasmodic; mydriatic; preanesthetic medicant
Definition
ChEBI: A hydrobromide that is obtained by reaction of scopolamine with hydrogen bromide.
Brand name
Isopto Hyoscine (Alcon); Transderm-Scop (Ciba-Geigy).
General Description
Different sources of media describe the General Description of 114-49-8 differently. You can refer to the following data:
1. Scopolamine hydrobromide(hyoscine hydrobromide) occurs as white orcolorless crystals or as a white, granular powder. It is odorlessand tends to effloresce in dry air. It is freely soluble inwater (1:1.5), soluble in alcohol (1:20), only slightly solublein chloroform, and insoluble in ether.Scopolamine is a competitive blocking agent of theparasympathetic nervous system as is atropine, but it differsmarkedly from atropine in its action on the higher nervecenters. Both drugs readily cross the blood-brain barrierand, even at therapeutic doses, cause confusion, particularlyin the elderly.
2. Colorless crystals or white powder or solid. Has no odor. pH (of 5% solution): 4-5.5. Slightly efflorescent in dry air. Bitter, acrid taste.
Air & Water Reactions
Sensitive to air, light and moisture. Water soluble.
Reactivity Profile
Scopolamine hydrobromide is incompatible with acids, bases and oxidizing agents. .
Fire Hazard
Flash point data for Scopolamine hydrobromide are not available; however, Scopolamine hydrobromide is probably combustible.
Biological Activity
Non-selective muscarinic antagonist. Widely used clinically to treat motion sickness.
Clinical Use
A sufficiently large dose of scopolamine will cause an individualto sink into a restful, dreamless sleep for about8 hours, followed by a period of approximately the samelength in which the patient is in a semiconscious state.During this time, the patient does not remember events thattake place. When scopolamine is administered with morphine,this temporary amnesia is termed twilight sleep.
Drug interactions
Potentially hazardous interactions with other drugs
None known
Metabolism
Hyoscine hydrobromide is almost entirely metabolised,
probably in the liver; only a small proportion of an oral
dose is excreted unchanged in the urine. In one study in
man, 3.4% of a single dose, administered by subcutaneous
injection was excreted unchanged in urine within 72
hours.
Purification Methods
The hydrobromide is recrystallised from Me2CO, H2O or EtOH/Et2O and dried. It is soluble in H2O (60%) and EtOH (5%) but insoluble in Et2O and slightly in CHCl3. The hydrochloride has m 300o (from Me2CO). The free base is a viscous liquid which forms a crystalline hydrate with m 59o and [] D 20 -28o (c 2.7, H2O). It hydrolyses in dilute acid or base. [Meinwald J Chem Soc 712 1953, Fodor Tetrahedron 1 86 1957, Beilstein 6 III 4185.]
Check Digit Verification of cas no
The CAS Registry Mumber 114-49-8 includes 6 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 3 digits, 1,1 and 4 respectively; the second part has 2 digits, 4 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 114-49:
(5*1)+(4*1)+(3*4)+(2*4)+(1*9)=38
38 % 10 = 8
So 114-49-8 is a valid CAS Registry Number.
InChI:InChI=1/C17H21NO4.BrH/c1-18-13-7-11(8-14(18)16-15(13)22-16)21-17(20)12(9-19)10-5-3-2-4-6-10;/h2-6,11-16,19H,7-9H2,1H3;1H/t11-,12-,13+,14?,15-,16?;/m1./s1
114-49-8Relevant articles and documents
Process for the manufacture of tropenol
-
, (2008/06/13)
A process for preparing tropenol (I) or an acid addition salt thereof, the process comprising: (a) reducing a scopine ester of formula (II) ?wherein R is C1-C4-alkyl or C1-C4-alkylene-phenyl, each optionally substituted by hydroxy or C1-C4-alkoxy, ?or an acid addition salt or hydrate thereof, using zinc in a suitable solvent in the presence of an activating metal salt; and (b) saponifying the product of (a) using a suitable base to obtain the tropenol of formula (I) or the acid addition salt thereof.